Emergence of resistance to cephalothin and gentamicin during combination therapy for methicillin-resistant Staphylococcus aureus endocarditis in rabbits.
D000818:Animals; D001426:Bacterial Proteins; D002352:Carrier Proteins / Q000032:analysis; D002512:Cephalothin / Q000494:pharmacology / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004697:Endocarditis, Bacterial / Q000188:drug therapy* / Q000382:microbiology; D005839:Gentamicins / Q000494:pharmacology / Q000627:therapeutic use*; D006602:Hexosyltransferases; D008564:Membrane Potentials; D008712:Methicillin / Q000494:pharmacology; D002267:Muramoylpentapeptide Carboxypeptidase / Q000032:analysis; D010403:Penicillin Resistance; D046915:Penicillin-Binding Proteins; D010458:Peptidyl Transferases; D011817:Rabbits; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000382:microbiology; D013211:Staphylococcus aureus / Q000187:drug effects / Q000378:metabolism; D013307:Streptomycin / Q000378:metabolism
D001426:Bacterial Proteins; D002352:Carrier Proteins; D005839:Gentamicins; D046915:Penicillin-Binding Proteins; D010458:Peptidyl Transferases; D006602:Hexosyltransferases; D002267:Muramoylpentapeptide Carboxypeptidase; D008712:Methicillin; D002512:Cephalothin; D013307:Streptomycin